Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life

Abstract Background Achalasia is a rare esophageal motility disorder with an estimated annual incidence of 1–5/100.000 and a mean age at diagnosis > 50 years of age. Only a fraction of the patients has an onset during childhood (estimated incidence of 0.1–0.18/ 100.000 children per year). No cura...

Full description

Saved in:
Bibliographic Details
Main Authors: Thijs Kuipers, Carlijn Mussies, Aaltje Lei, Gwen M.C. Masclee, Marc A. Benninga, Paul Fockens, Barbara A.J. Bastiaansen, Albert J. Bredenoord, Michiel P. van Wijk
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03565-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585383779500032
author Thijs Kuipers
Carlijn Mussies
Aaltje Lei
Gwen M.C. Masclee
Marc A. Benninga
Paul Fockens
Barbara A.J. Bastiaansen
Albert J. Bredenoord
Michiel P. van Wijk
author_facet Thijs Kuipers
Carlijn Mussies
Aaltje Lei
Gwen M.C. Masclee
Marc A. Benninga
Paul Fockens
Barbara A.J. Bastiaansen
Albert J. Bredenoord
Michiel P. van Wijk
author_sort Thijs Kuipers
collection DOAJ
description Abstract Background Achalasia is a rare esophageal motility disorder with an estimated annual incidence of 1–5/100.000 and a mean age at diagnosis > 50 years of age. Only a fraction of the patients has an onset during childhood (estimated incidence of 0.1–0.18/ 100.000 children per year). No curative treatment is currently available. Peroral Endoscopic Myotomy (POEM) is a widely accepted treatment option to improve symptoms in adults. Studies evaluating safety and efficacy of POEM in children are scarce and no data exist regarding the quality of life in patients after POEM. Methods We evaluated the effectiveness and safety of POEM in a cohort of children that was treated for achalasia and we prospectively evaluated their quality of life. We compared the results to a previous cohort evaluating Pneumatic Dilation (PD) and Laparoscopic Heller’s Myotomy (LHM) in children with achalasia. Results Thirty-three achalasia patients (age at time of POEM 14.1(± 2.5) years, 54.5% female) were included. Twenty-nine (87.8%) percent had received previous treatment (PD (n = 20); LHM (n = 1); PD + LHM (n = 7); PD + Botox (n = 1). POEM was technically successful in all patients and no major complications occurred. Mean follow-up duration was 33 (± 25) months. Twenty three (70%) patients did not need retreatment after POEM during the follow up period. Quality of life after POEM did not differ from the population norms. Patients with an Eckardt score > 3 had a significantly worse general (Kidscreen-52: physical score 44.7 vs. 52.4; p = 0.011; mental score: 42.5 vs. 51.3; p = 0.038) and disease specific (35 vs. 16; p = 0.017) quality of life compared to those with an Eckardt ≤ 3. The SF-36 mental health component score was significantly lower (44.2 vs. 53.1; p = 0.036) in patients treated with POEM compared to those treated with PD and LHM. These lower scores could be related to a selection bias, as more severe patients received POEM, and other influences such as the Corona pandemic. However, the overall, quality of life after POEM was not significantly different to PD and LHM. Conclusion POEM is an effective and safe treatment for achalasia in children. Quality of life after POEM is comparable to the results obtained after PD and Heller.
format Article
id doaj-art-c856913d57a947d99a8b0e86917d6c5a
institution Kabale University
issn 1750-1172
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-c856913d57a947d99a8b0e86917d6c5a2025-01-26T12:52:15ZengBMCOrphanet Journal of Rare Diseases1750-11722025-01-012011910.1186/s13023-025-03565-yPeroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of lifeThijs Kuipers0Carlijn Mussies1Aaltje Lei2Gwen M.C. Masclee3Marc A. Benninga4Paul Fockens5Barbara A.J. Bastiaansen6Albert J. Bredenoord7Michiel P. van Wijk8Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Pediatric Gastroenterology and Nutrition, Amsterdam UMC, Emma Children’s Hospital, University of AmsterdamDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Pediatric Gastroenterology and Nutrition, Amsterdam UMC, Emma Children’s Hospital, Vrije UniversiteitDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of AmsterdamDepartment of Pediatric Gastroenterology and Nutrition, Amsterdam UMC, Emma Children’s Hospital, Vrije UniversiteitAbstract Background Achalasia is a rare esophageal motility disorder with an estimated annual incidence of 1–5/100.000 and a mean age at diagnosis > 50 years of age. Only a fraction of the patients has an onset during childhood (estimated incidence of 0.1–0.18/ 100.000 children per year). No curative treatment is currently available. Peroral Endoscopic Myotomy (POEM) is a widely accepted treatment option to improve symptoms in adults. Studies evaluating safety and efficacy of POEM in children are scarce and no data exist regarding the quality of life in patients after POEM. Methods We evaluated the effectiveness and safety of POEM in a cohort of children that was treated for achalasia and we prospectively evaluated their quality of life. We compared the results to a previous cohort evaluating Pneumatic Dilation (PD) and Laparoscopic Heller’s Myotomy (LHM) in children with achalasia. Results Thirty-three achalasia patients (age at time of POEM 14.1(± 2.5) years, 54.5% female) were included. Twenty-nine (87.8%) percent had received previous treatment (PD (n = 20); LHM (n = 1); PD + LHM (n = 7); PD + Botox (n = 1). POEM was technically successful in all patients and no major complications occurred. Mean follow-up duration was 33 (± 25) months. Twenty three (70%) patients did not need retreatment after POEM during the follow up period. Quality of life after POEM did not differ from the population norms. Patients with an Eckardt score > 3 had a significantly worse general (Kidscreen-52: physical score 44.7 vs. 52.4; p = 0.011; mental score: 42.5 vs. 51.3; p = 0.038) and disease specific (35 vs. 16; p = 0.017) quality of life compared to those with an Eckardt ≤ 3. The SF-36 mental health component score was significantly lower (44.2 vs. 53.1; p = 0.036) in patients treated with POEM compared to those treated with PD and LHM. These lower scores could be related to a selection bias, as more severe patients received POEM, and other influences such as the Corona pandemic. However, the overall, quality of life after POEM was not significantly different to PD and LHM. Conclusion POEM is an effective and safe treatment for achalasia in children. Quality of life after POEM is comparable to the results obtained after PD and Heller.https://doi.org/10.1186/s13023-025-03565-yEsophagusMotility disorderAchalasiaEndoscopyQuality of life
spellingShingle Thijs Kuipers
Carlijn Mussies
Aaltje Lei
Gwen M.C. Masclee
Marc A. Benninga
Paul Fockens
Barbara A.J. Bastiaansen
Albert J. Bredenoord
Michiel P. van Wijk
Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
Orphanet Journal of Rare Diseases
Esophagus
Motility disorder
Achalasia
Endoscopy
Quality of life
title Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
title_full Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
title_fullStr Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
title_full_unstemmed Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
title_short Peroral Endoscopic myotomy (POEM) in pediatric achalasia: a retrospective cohort on institutional experience and quality of life
title_sort peroral endoscopic myotomy poem in pediatric achalasia a retrospective cohort on institutional experience and quality of life
topic Esophagus
Motility disorder
Achalasia
Endoscopy
Quality of life
url https://doi.org/10.1186/s13023-025-03565-y
work_keys_str_mv AT thijskuipers peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT carlijnmussies peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT aaltjelei peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT gwenmcmasclee peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT marcabenninga peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT paulfockens peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT barbaraajbastiaansen peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT albertjbredenoord peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife
AT michielpvanwijk peroralendoscopicmyotomypoeminpediatricachalasiaaretrospectivecohortoninstitutionalexperienceandqualityoflife